Search

everythinglearnresearchcommunity

for

Search:↓

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Pediatric endocrinologists should provide early fertility counseling and preservation options to young patients at risk of infertility.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Accurate diagnosis and timely, tailored treatments improve outcomes in obstetrics and gynecology.

Inclusive and affirming healthcare is essential for improving transgender individuals' quality of life and health.

A 20-year-old woman with a rare form of Turner syndrome showed improvement with hormonal therapy and needs comprehensive care.

Women with nonclassical congenital adrenal hyperplasia may have a higher risk of fertility issues and miscarriages, and should get genetic counseling.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

Greater intimacy leads to better self-reported health in couples having infertility treatment.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

PCOS is managed by lifestyle changes and personalized medication to improve symptoms and fertility.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

Experts agree that PCOS affects women's health in complex ways, but more research is needed to understand and treat it effectively.

Finasteride may improve sperm count in subfertile men with low sperm count.

Some dermatological medications can impair male fertility, so consult a doctor before trying to conceive.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Paternal drug exposure can harm fertility, pregnancy outcomes, and offspring health, with specific drugs linked to various reproductive issues.

Stopping the use of the drug finasteride can improve sperm count and does not prevent normal conception, but caution is advised when trying to conceive.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

The document concludes that women with PCOS need a comprehensive care model that covers reproductive, metabolic, and psychological health to improve their quality of life.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

Some congenital hair disorders improve in childhood or with treatments like minoxidil and retinoids, while others like Netherton syndrome and trichothiodystrophy have a poor prognosis.